DiaSorin SpA
Andrea Armando has over 15 years of experience in regulatory affairs. Andrea is currently working at DiaSorin as the Senior Corporate Director, Regulatory Affairs. Prior to this role, they held positions as the Corporate Director, Regulatory Affairs, and Senior Manager, Corporate Regulatory Affairs at the same company. Before joining DiaSorin, Andrea worked as the Quality and Regulatory Affairs Manager at Empatica. Andrea also worked as the Regulatory Affairs Manager and Regulatory Affairs Senior Specialist at LivaNova. Andrea's career in regulatory affairs started at Medevice S.r.l., where they served as a Project Manager/Regulatory Affairs Unit.
Andrea Armando attended the University of Turin, Faculty of Pharmacy from 2001 to 2006, where they obtained a degree in Chemistry and Pharmaceutical Technologies. Andrea also obtained a certification in RAC-DEVICES from the Regulatory Affairs Certification Program in June 2019.
This person is not in any offices
DiaSorin SpA
4 followers
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company's business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.